Weikang Pingsheng
Daxing
About Weikang Pingsheng
Weikang Pingsheng is a pharmaceutical delivery technology developer. Based on lipid droplet biology, it has developed a worldwide unique "fat body" medication delivery platform that replicates natural lipoprotein particles in the human body and obtains artificial fat bodies by nano-preparation technology. As a medication packaging and targeted delivery method, it is commonly utilized to deliver small molecule revolutionary pharmaceuticals, antibodies, innovative nucleic acid drugs, recombinant protein vaccines, minerals, and medicinal extracts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2026)
Industries & Categories
Biopharma, Biotechnology, Medical
Canonical: https://fsome.com/organization/weikang-pingsheng-2204259 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.